Back to Results

Precipio Inc (PRPO)

Precipio Inc. is a healthcare biotechnology company listed on NASDAQ under the ticker PRPO. As an ordinary common stock issue, the security represents equity in the company rather than a specialized fund or structured instrument. The company focuses on cancer diagnostics in the United States, with products, reagents, and services centered on blood cancer testing. Its offerings include IV-Cell, a proprietary cell culture medium designed to support simultaneous growth of four hematopoietic cell lineages, and HemeScreen, a set of genetic diagnostic panels. Precipio also provides biomarker testing and clinical project services to biopharma customers. The company is based in New Haven, Connecticut.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NASDAQ-PRPO
$24.61
-6.3% Downside
Fair
Not available
Not available
Good
0.0%
3.2x
1.7x
47.019 M
47.532 M
7.0%
78.6%
-6.7
-64.9%
Valuation • Fair Value

Precipio Inc (NASDAQ-PRPO) Fair Value by Valuation Model

Review the available estimates for Precipio Inc (NASDAQ-PRPO), including EPV Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$24.61

Estimated downside of 6.3% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

EPV Fair Value

$21.41

Earnings power value estimate.

Comps Fair Value

$25.25

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 4 available valuation references for Precipio Inc (NASDAQ-PRPO) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Precipio Inc (NASDAQ-PRPO)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

27.198 M

Current operating scale indicator.

Revenue Forecast

80.256 M

Forward revenue estimate.

EBITDA

-129 K

Current operating profitability reference.

EBITDA Forecast

-3.084 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Precipio Inc (NASDAQ-PRPO) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Precipio Inc (NASDAQ-PRPO)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Good

Positive financial-health read.

Piotroski Score

5

Mid-range quality score.

Beneish M-Score

-2.56

No elevated caution signal from this screen.

Altman Z-Score

-6.7

Lower score that deserves closer risk review.

FCF / Net Income

-64.9%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Precipio Inc (NASDAQ-PRPO). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Dividend Profile for Precipio Inc (NASDAQ-PRPO)

Review the dividend metrics currently supported by the latest data.

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

The latest data indicates no current dividend yield for Precipio Inc (NASDAQ-PRPO). No upcoming dividend amount or event date is currently available.

Stock Forecast • Technical Outlook

Precipio Inc (NASDAQ-PRPO) Stock Forecast & Technical Outlook

Review Precipio Inc (NASDAQ-PRPO) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Precipio Inc (NASDAQ-PRPO) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Precipio Inc (NASDAQ-PRPO) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for Precipio Inc (NASDAQ-PRPO) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Precipio Inc (NASDAQ-PRPO) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Precipio Inc (NASDAQ-PRPO) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Precipio Inc (NASDAQ-PRPO)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Precipio Inc (NASDAQ-PRPO) has a Strong Buy consensus, with 1 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 0
Sell 0
FAQ • Fast Investor Answers

Precipio Inc (NASDAQ-PRPO) Stock FAQ

Data-supported answers about Precipio Inc (NASDAQ-PRPO), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$24.61
Estimated downside 6.3%
Valuation Rating
Overvalued
Estimated downside of 6.3%
Financial Health
Good
Current financial-health read

The current fair value estimate for Precipio Inc (NASDAQ-PRPO) is $24.61. This implies an estimated downside of 6.3% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 6.3% versus the current market price.

The current financial health read for Precipio Inc (NASDAQ-PRPO) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The latest available data indicates no current dividend yield for Precipio Inc (NASDAQ-PRPO).

The current market capitalization listed for Precipio Inc is 47.019 M.

The current enterprise value listed for Precipio Inc is 47.532 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Precipio Inc is NASDAQ-PRPO, and the stock is listed on NASDAQ.

Precipio Inc (NASDAQ-PRPO) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Precipio Inc is 7.0%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Precipio Inc is 78.6%. Free float helps investors understand how much of the share base is available for public trading.

Similar Healthcare Providers & Services Stocks View more on NASDAQ

Comparable companies from the same industry, limited to one security per issuer.

UNH NYSE Unitedhealth Group Fair Value Undervalued Market Cap 334.8 B
CVS NYSE CVS Health Corp Fair Value Undervalued Market Cap 111.4 B
MCK NYSE McKesson Corporation Fair Value Undervalued Market Cap 103.9 B
HCA NYSE HCA Holdings Inc Fair Value Fair Market Cap 94.854 B
ELV NYSE Elevance Health Inc Fair Value Fair Market Cap 87.275 B
CI NYSE Cigna Corp Fair Value Bargain Market Cap 72.333 B
COR NYSE Cencora Inc Fair Value Fair Market Cap 60.002 B
CAH NYSE Cardinal Health Inc Fair Value Fair Market Cap 51.415 B
HUM NYSE Humana Inc Fair Value Fair Market Cap 44.67 B
CNC NYSE Centene Corp Fair Value Undervalued Market Cap 31.27 B
DGX NYSE Quest Diagnostics Incorporated Fair Value Fair Market Cap 25.911 B
LH NYSE Labcorp Holdings Inc Fair Value Fair Market Cap 25.266 B
GH NASDAQ Guardant Health Inc Fair Value Overvalued Market Cap 23.774 B
THC NYSE Tenet Healthcare Corporation Fair Value Fair Market Cap 21.101 B
EHC NYSE Encompass Health Corp Fair Value Fair Market Cap 12.111 B
FMS NYSE Fresenius Medical Care Corporation Fair Value Undervalued Market Cap 11.925 B
BTSG NASDAQ Brightspring Health Services Inc Fair Value Fair Market Cap 11.79 B
DVA NYSE DaVita HealthCare Partners Inc Fair Value Fair Market Cap 11.716 B
UHS NYSE Universal Health Services Inc Fair Value Undervalued Market Cap 10.567 B
ENSG NASDAQ The Ensign Group Inc Fair Value Fair Market Cap 10.19 B